Patient blood management» strategy in pregnant women with the risk of massive obstetric bleeding

The objective: a determination of the effectiveness anemia treatment with intravenous iron (III) hydroxide sucrose complex in pregnant women pathological placentation, as first stage “patient blood management” before delivery.Materials and methods. Among 86 placental pathology, 58 (70.7 %) had anemia. Severe hemoglobin level <70 g/l was 13 (22.4 %), moderate <90 — 19 (32.8 %). group included 18 (31.1 placenta previa periodic loss during pregnancy. second consisted 40 (68.9 invasive placenta. gestation period all 33+6 weeks. Anemia treated by administering 3 times week (5-7 injections).Results. main factor that led to placentation scar on uterus. In placenta, uterus 38 (95 women. present 2 (11.1 2.4 less than 11 (27.5 Moderate 4 (22.2 15 (37.5 group.In severe anemia, after 5–7 injections drug increased significantly 30 g/l, number erythrocytes 2.8×1012/l, serum – times, ferritin 19.6 μg/l transferrin content decreased. For 3–5 were sufficient normalize indicators. Normalization parameters allowed reduce risk bleeding, transfusions improve outcomes.Conclusions. Timely diagnosis deficiency pathology is an important means preventing massive reducing transfusions, strategy management”.Intravenous has demonstrated high clinical efficacy can be recommended for widespread use practical medicine.